0001562180-24-000365.txt : 20240109 0001562180-24-000365.hdr.sgml : 20240109 20240109160929 ACCESSION NUMBER: 0001562180-24-000365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240105 FILED AS OF DATE: 20240109 DATE AS OF CHANGE: 20240109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gregory Philip D CENTRAL INDEX KEY: 0001343543 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40791 FILM NUMBER: 24523359 MAIL ADDRESS: STREET 1: POINT RICHMOND TECH CENTER II STREET 2: 501 CANAL BOULEVARD SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 2seventy bio, Inc. CENTRAL INDEX KEY: 0001860782 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863658454 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-01-05 false 0001860782 2seventy bio, Inc. TSVT 0001343543 Gregory Philip D 60 BINNEY STREET CAMBRIDGE MA 02142 false true false false Chief Scientific Officer false Common Stock 2024-01-05 4 S false 795.00 3.7536 D 230842.00 D Common Stock 2024-01-08 4 A false 79438.00 0.00 A 310280.00 D Stock Option (Right to buy) 3.97 2024-01-08 4 A false 158875.00 0.00 A 2034-01-08 Common Stock 158875.00 158875.00 D Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.675 to $3.83, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. RSU awards vest over a four-year period at the rate of 25% on 01/02/2025, 25% on 01/02/2026, 25% on 01/02/2027, and 25% on 01/02/2028. This stock option vests over a four-year period at the rate of 25% on 01/02/2025, and then in 36 equal monthly installments thereafter. /s/ Teresa Jurgensen, Attorney-in-Fact 2024-01-09